Taylor, Cottrill, Erickson & Associates, Inc. Novo Nordisk A S Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$340 Million
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$95.88 - $117.08 $1.33 Million - $1.63 Million	-13,910 Closed	0 $0
Q3 2021 Oct 15, 2021	SELL	$84.42 - $106.62 $4,221 - $5,331	-50 Reduced 0.36%	13,910 $1.34 Million
Q1 2020 Apr 15, 2020	BUY	$49.46 - $64.78 $9,892 - $12,956	200 Added 1.45%	13,960 $840,000
Q4 2019 Jan 14, 2020	BUY	$49.86 - $58.26 $19,944 - $23,304	400 Added 2.99%	13,760 $796,000
Q3 2019 Oct 25, 2019	BUY	$47.54 - $53.43 $40,409 - $45,415	850 Added 6.79%	13,360 $691,000

Q2 2019 Jul 26, 2019	BUY	$46.79 - $52.47 $325,190 - $364,666	6,950 Added 125.0%	12,510 $639,000
Q1 2019 Apr 29, 2019	BUY	$46.36 - $52.63 $28,975 - $32,893	625 Added 12.66%	5,560 $291,000
Q4 2018 Jan 29, 2019	BUY	$41.54 - $47.25 $204,999 - $233,178	4,935 New	4,935 $227,000

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account